(Q38234198)

31 August 2017

Infectious diarrhea: an overview (English)

1 reference

31 August 2017

0 references

Christina M. Surawicz

series ordinal

2

object named as

Christina M Surawicz

1 reference

31 August 2017

Brandon Dickinson

1

1 reference

31 August 2017

1 August 2014

1 reference

Current gastroenterology reports

31 August 2017

1 reference

31 August 2017

16

1 reference

31 August 2017

8

1 reference

31 August 2017

399

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-014-0399-8

31 August 2017

0 references

cites work

Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006.

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Open-Source Genomic Analysis of Shiga-Toxin–Producing E. coli O104:H4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Deaths associated with bacterial pathogens transmitted commonly through food: foodborne diseases active surveillance network (FoodNet), 1996-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Multistate outbreak of listeriosis associated with cantaloupe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Transmission risk factors and treatment of pediatric shigellosis during a large daycare center-associated outbreak of multidrug resistant Shigella sonnei: implications for the management of shigellosis outbreaks among children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Emerging therapies for Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Disease transmission model for community-associated Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

The epidemiology of Clostridium difficile infection in children: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

The epidemiology of community-acquired Clostridium difficile infection: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Clostridium difficile--more difficult than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Harnessing microbiota to kill a pathogen: Fixing the microbiota to treat Clostridium difficile infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Bile salts and glycine as cogerminants for Clostridium difficile spores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Harnessing microbiota to kill a pathogen: the sweet tooth of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Oral rehydration therapy in the second decade of the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Oral rehydration solution in the year 2000: pathophysiology, efficacy and effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

D-glucose acts via sodium/glucose cotransporter 1 to increase NHE3 in mouse jejunal brush border by a Na+/H+ exchange regulatory factor 2-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Scientific rationale for a change in the composition of oral rehydration solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Amylase-resistant starch plus oral rehydration solution for cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Amylase-resistant starch as adjunct to oral rehydration therapy in children with diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

A randomized controlled trial of glucose versus amylase resistant starch hypo-osmolar oral rehydration solution for adult acute dehydrating diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Zinc supplementation in public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

21 January 2018

Mechanisms of diarrhea

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Zinc inhibits cholera toxin-induced, but not Escherichia coli heat-stable enterotoxin-induced, ion secretion in human enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Zinc inhibits calcium-mediated and nitric oxide-mediated ion secretion in human enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Mechanisms of action of zinc in acute diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Zinc status and immune system relationship: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

21 January 2018

Post-dysenteric colitis.

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Post-infectious irritable bowel syndrome: the past, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Alterations in human intestinal microflora during experimental diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

A new rat model links two contemporary theories in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-014-0399-8

Evaluation of oral rehydration solution by whole-gut perfusion in rats: effect of osmolarity, sodium concentration and resistant starch

21 January 2018

1 reference

12 December 2020

Toxins and the gut: role in human disease.

1 reference

12 December 2020

Community-acquired Clostridium difficile infection: an increasing public health threat

1 reference

12 December 2020

Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea

1 reference

12 December 2020

Notes from the field: Outbreak of infections caused by Shigella sonnei with decreased susceptibility to azithromycin--Los Angeles, California, 2012.

1 reference

12 December 2020

Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization

1 reference

12 December 2020

Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection

1 reference

12 December 2020

Incidence and trends of infection with pathogens transmitted commonly through food - foodborne diseases active surveillance network, 10 U.S. sites, 1996-2012.

1 reference

12 December 2020

Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients

1 reference

12 December 2020

10.1007/S11894-014-0399-8

Identifiers

DOI

1 reference

PubMed ID

25064318

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

25064318